SRX HEALTH SOLUTIONS INC (SRXH) Stock Analyst Earnings Estimates
NYSEARCA:SRXH - NYSE Arca - US08771Y4026 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 54.66M 18.81% | 38.592M -29.40% | 34.975M -9.37% | 255M 629.09% | |
| EBITDA YoY % growth | -18.479M -18.34% | -10.969M 40.64% | -5.837M 46.79% | 1.938M 133.20% | |
| EBIT YoY % growth | -20.169M -16.73% | -12.647M 37.29% | -5.967M 52.82% | 10.2M 270.94% | |
| Operating Margin | -36.90% | -32.77% | -17.06% | 4.00% | |
| EPS YoY % growth | -31.24 -466.36% | N/A 99.22% | N/A 37.50% | 0.27 273.33% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.50 -390.20% | -0.10 | -0.40 | -390.20% |
| Q3 2024 Q2Q % growth | -0.54 -980.00% | -0.06 | -0.48 | -782.35% |
| Q2 2024 Q2Q % growth | -1.02 76.82% | -0.05 | -0.97 | -1,900.00% |
| Q1 2024 Q2Q % growth | 100.00% | 0.00 | % | |
| Q4 2023 Q2Q % growth | 98.84% | -0.10 | % | |
| Q3 2023 Q2Q % growth | -0.05 99.48% | -0.06 | 0.01 | 18.30% |
| Q2 2023 Q2Q % growth | -4.40 33.33% | -2.24 | -2.16 | -96.08% |
| Q1 2023 Q2Q % growth | -4.84 21.43% | -1.35 | -3.49 | -259.48% |
| Q4 2022 Q2Q % growth | -8.80 | -6.43 | -2.37 | -36.80% |
| Q3 2022 Q2Q % growth | -9.68 -83.33% | -6.96 | -2.72 | -39.15% |
| Q2 2022 Q2Q % growth | -6.60 -112.61% | -4.71 | -1.89 | -40.06% |
| Q1 2022 Q2Q % growth | -6.16 | -6.28 | 0.12 | 1.96% |
| Q4 2021 Q2Q % growth | -8.80 | -5.39 | -3.41 | -63.40% |
| Q3 2021 Q2Q % growth | -5.28 | -4.19 | -1.09 | -26.05% |
| Q2 2021 Q2Q % growth | 52.36 | -3.59 | 55.95 | 1,558.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 7.16M -9.40% | % | ||
| Q4 2024 Q2Q % growth | 7.16M 25.57% | 13.158M | -5.998M | -45.58% |
| Q3 2024 Q2Q % growth | 11.37M -13.32% | 15.81M | -4.44M | -28.08% |
| Q2 2024 Q2Q % growth | 8.542M -18.93% | 22.44M | -13.898M | -61.93% |
| Q1 2024 Q2Q % growth | 7.903M -14.44% | 22.848M | -14.945M | -65.41% |
| Q4 2023 Q2Q % growth | 5.702M -38.46% | 11.424M | -5.722M | -50.09% |
| Q3 2023 Q2Q % growth | 13.117M 10.55% | 14.076M | -959K | -6.81% |
| Q2 2023 Q2Q % growth | 10.536M -36.20% | 19.89M | -9.354M | -47.03% |
| Q1 2023 Q2Q % growth | 9.237M -45.71% | 17.748M | -8.511M | -47.95% |
| Q4 2022 Q2Q % growth | 9.266M -15.66% | 12.024M | -2.758M | -22.94% |
| Q3 2022 Q2Q % growth | 11.865M -10.11% | 14.331M | -2.466M | -17.21% |
| Q2 2022 Q2Q % growth | 16.515M 50.29% | 15.387M | 1.128M | 7.33% |
| Q1 2022 Q2Q % growth | 17.014M 57.10% | 15.547M | 1.467M | 9.44% |
| Q4 2021 Q2Q % growth | 10.987M 18.29% | 11.236M | -249K | -2.22% |
| Q3 2021 Q2Q % growth | 13.2M 18.55% | 12.954M | 246K | 1.90% |
| Q2 2021 Q2Q % growth | 10.989M 10.54% | 11.118M | -129K | -1.16% |
| Q1 2021 Q2Q % growth | 10.83M -11.42% | % | ||
| Q4 2020 Q2Q % growth | 9.288M 131.62% | % | ||
| Q3 2020 Q2Q % growth | 11.135M 183.19% | % | ||
| Q2 2020 Q2Q % growth | 9.941M 143.41% | % | ||
| Q1 2020 Q2Q % growth | 12.226M 244.30% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | N/A |
| Revenue | N/A | N/A | 0% | N/A |